KARL STORZ unifies its US organizations under a central management team, Sonal Matai named US President
06/02/2024
Enhanced organizational structure will drive innovation and improve engagement with and delivery of excellence to KARL STORZ customers, accelerating growth.
EL SEGUNDO, Calif. - KARL STORZ, a leading family-owned medical technology company, today announced it will centralize management of its United States organizations, including its research and development, manufacturing, and commercial operations, to bring more innovative products to market worldwide with greater speed. Sonal Matai, who has led the US commercial business for two years, has been named President of KARL STORZ in the United States and will lead the effort to bring this ambitious transformation to life.
“The U.S. is the world’s largest medical device market and also the largest market for KARL STORZ,” said Sonal Matai, US President of KARL STORZ. “Our 2,700 employees in the United States can now work together more closely to create an enhanced customer experience in this critical geography through innovative products and superior service.”
“Our new organizational structure will bring benefits to all our stakeholders. Our suppliers and vendor partners will benefit from streamlined interactions with an integrated KARL STORZ in the US,” Matai added.
Matai was previously Managing Director, KARL STORZ Endoscopy-America, Inc. In that role, he spearheaded a period of significant innovation and market share expansion. His prior leadership experiences at large MedTech companies and start-ups, as well as his global outlook and dedication to innovation and customer satisfaction, have honed his ability to drive progress and steer market leadership.
Press Contact:
Marketing Communications
KARL STORZ United States
Phone: (657)-385-5285